Equities

Krebs Biochemicals and Industries Ltd

KREBSBIO:NSI

Krebs Biochemicals and Industries Ltd

Actions
Consumer Staples Food Producers
  • Price (INR)88.77
  • Today's Change-1.82 / -2.01%
  • Shares traded3.79k
  • 1 Year change+38.38%
  • Beta1.0005
Data delayed at least 15 minutes, as of Sep 20 2024 10:44 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments0.690.170.32
Total Receivables, Net673190
Total Inventory102124259
Prepaid expenses3.765.184.93
Other current assets, total0.680.680.68
Total current assets174161355
Property, plant & equipment, net1,4951,4871,442
Goodwill, net------
Intangibles, net252729
Long term investments----0.00
Note receivable - long term635250
Other long term assets252323
Total assets1,7821,7501,898
LIABILITIES
Accounts payable190153379
Accrued expenses1102712
Notes payable/short-term debt99100100
Current portion long-term debt/capital leases2.471.341.83
Other current liabilities, total216210288
Total current liabilities618491781
Total long term debt1,8351,7321,329
Total debt1,9371,8341,431
Deferred income tax------
Minority interest------
Other liabilities, total521521539
Total liabilities2,9742,7442,649
SHAREHOLDERS EQUITY
Common stock216216216
Additional paid-in capital1,1801,1801,180
Retained earnings (accumulated deficit)(2702)(2505)(2261)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total114114114
Total equity(1192)(995)(751)
Total liabilities & shareholders' equity1,7821,7501,898
Total common shares outstanding222222
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.